Sanofi Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, and Other Innovation Programs

DUBLIN, Jan. 10, 2024 /PRNewswire/ -- The "Sanofi S.A - Digital Transformation Strategies" company profile has been added to  ResearchAndMarkets.com's offering.

This report provides insight into Sanofi's digital technology activities, including its digital transformation strategies, its accelerators, incubators, and other innovation programs, its technology initiatives, venture arm, investments, and its estimated ICT budget.

Sanofi S.A. (Sanofi) is a France-based multinational healthcare company. It is engaged in the discovery, development, manufacturing and marketing of a wide range of medicines and vaccines. Its product portfolio includes medicines for the treatment of cancer, diabetes, rare diseases, multiple sclerosis and cardiovascular diseases; human vaccines for protection against various bacterial and viral diseases; and consumer healthcare products for digestion, allergy, cough, cold, flu and sinus, pain, women's health, and supplements.

The company has three operating segments namely Vaccines, Pharmaceuticals, and Consumer Healthcare. The Pharmaceuticals segment comprises the operations of Specialty Care and General Medicines. The company reports its sales through four divisions namely General Medicines, Specialty Care, Vaccines and Consumer Healthcare.

The company is using several emerging technologies such as AI, ML, big data, and cloud among others, has launched accelerators and innovation hubs, and is partnering with and investing in digital companies to enhance operational efficiencies, quickly develop new medicines and vaccines, and improve patient outcomes.

Scope

• Sanofi is strengthening its focus on the use of innovative technologies to enhance operational efficiencies, quickly develop new medicines and vaccines, and improve patient outcomes. AI, ML, cloud, big data, virtual and augmented reality, connected care and robotics, are among the technologies the pharmaceutical company is focusing on.

Reasons to Buy

• Gain insights into Sanofi's digital transformation strategies.
• Gain insights into its technology themes under focus.
• Gain insights into its various product launches, partnerships, and investments.

Key Topics Covered:

• Overview
• Digital Transformation Strategy
• Accelerators, Incubators, and Other Innovation Programs
• Technology Focus
• Technology Initiatives
• Venture Arm: Sanofi Ventures
• Investment
• Partnership & Investment Network Map
• ICT Budget and Contracts
• Key Executives

A selection of companies mentioned in this report includes

• Medical Intelligence Service
• DarioHealth
• Deloitte
• Aqemia
• Exscientia
• Yseop
• Abdul Latif Jameel Clinic for Machine Learning in Health
• Owkin
• CytoReason
• SRI International
• Capgemini
• Ypso-Facto
• CentraleSupelec
• Babylon
• Happify
• Voxly Digital
• Google
• Atman
• Researchably
• McLaren Racing
• Evidation
• Capgemini
• Generali
• Orange
• Health2Sync
• Aetion
• Cegedim
• MDConnect
• TrialSpark
• TriNetX
• HakoBio
• Abbott
• Gyenno
• Vizibl
• Clip Health
• Cathay Innovation
• Omada Health
• Click Therapeutics
• Aetion
• Nucleai
• Medisafe
• CytoReason
• BioMed X
• Glooko

For more information about this company profile visit https://www.researchandmarkets.com/r/kwrwr9

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo - https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets